chartexchange

Cellectar Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

GlobeNewswire Inc. | Nov 10, 2026 7:15 AM EST

Presented updated data at the International Workshop for Waldenström Macroglobulinemia (IWWM) supporting the planned accelerated approval strategy for iopofosine I 131 in Waldenström macroglobulinemia (WM)

Read original article